Stem cells within gel microenvironments

• US 20070116680A1
• Filed: 09/15/2006
• Published: 05/24/2007
• Est. Priority Date: 11/18/2005
• Status: Abandoned Application

• Current Assignee: Rensselaer Polytechnic Institute
• Original Assignee: Rensselaer Polytechnic Institute
• Inventors: Lord, Evan, Stegemann, Jan
• Application Number:
  US11/521,315
• Publication Number:
  US 20070116680A1
• Time in Patent Office: Days
• US Class Current: 424/93.700
• CPC Class Codes: A61K 2035/126 Immunoprotecting barriers, e.g. jackets, diffusion chambers
• CPC Class Codes: A61K 9/0019 Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner non-active ingredients are additionally classified in A61K47/00
• CPC Class Codes: A61K 9/5036 Polysaccharides, e.g. gums, alginate; Cyclodextrin
• CPC Class Codes: A61K 9/5052 Proteins, e.g. albumin
• CPC Class Codes: A61K 9/5057 Gelatin
• CPC Class Codes: C12N 2533/52 Fibronectin; Laminin
• CPC Class Codes: C12N 2533/54 Collagen; Gelatin
• CPC Class Codes: C12N 2533/70 Polysaccharides
• CPC Class Codes: C12N 2533/72 Chitin, chitosan
• CPC Class Codes: C12N 5/0663 Bone marrow mesenchymal stem cells (BM-MSC)

Abstract

This invention provides a system to embed stem cells within three-dimensional (3D) hydrogel microenvironments consisting of naturally derived proteins, proteoglycans and/or polysaccharides. Pure matrices or combinations of materials can be used. The method involves suspending stem cells in solutions of the matrix components of interest, emulsifying these solutions in a hydrophobic phase, triggering gelation of the matrix components by changing the environmental conditions, and collection of the resulting hydrogel beads. The unique bead format of this invention has the advantage of allowing the use of small amounts of rare matrix proteins. Bead preparations can be concentrated into a paste for use as a cell delivery vehicle to damaged tissues, either directly after encapsulation or after a period of culture to promote stem cell differentiation. Defined 3D microenvironments can guide stem cell differentiation, and the resulting beads can be used directly as a cell delivery vehicle in various tissue repair applications.

Claims

1. A method of encapsulating stem cells within three-dimensional polymer microenvironments, wherein said polymer is a naturally derived polymer obtained from living organisms, wherein said method comprises the following steps:

(i) mixing a polymer solution with stem cells in a buffer to incorporate and disperse the stem cells therein to form a cell-liquid suspension,

(ii) emulsifying said cell-liquid suspension in a hydrophobic fluid phase to form an emulsified liquid,

(iii) initiating polymerization of said emulsified liquid to form three-dimensional polymer microenvironments, and

(iv) collecting the three-dimensional polymer microenvironments from the hydrophobic phase.

2. The method of claim 1, further comprising culturing the three-dimensional polymer microenvironments to promote differentiation of the stem cells into cells of a specific tissue type, wherein said tissue is selected from the group consisting of bone, cartilage, fat, skeletal muscle, smooth muscle, endothelial, epithelial, heart, muscle and nerve.

3. The method according to claim 1, wherein said hydrophobic fluid phase is selected from the group consisting of silicone oil, mineral oil, vegetable oil, room-temperature ionic liquids and combinations thereof.

4. The method according to any one of claims 1 or 2, wherein said polymer is selected from the group consisting of collagen, elastin, fibrinogen, fibrin, fibronectin, gelatin, laminin, vitronectin, hyaluronan, heparan sulfate, agar, agarose, alginate, chitosan and combinations thereof.

5. The method according to any one of claims 1 or 2, wherein said polymer is selected from the group consisting of collagen-gelatin, collagen-agarose, collagen-chitosan, collagen-chitosan-agarose, collagen-chitosan-gelatin, collagen-vitronectin-agarose, collagen-vitronectin-gelatin, collagen-vitronectin-chitosan, collagen-fibronectin-agarose, collagen- fibronectin-gelatin collagen- fibronectin-chitosan, collagen-laminin-agarose, collagen-laminin-gelatin, collagen-laminin-chitosan.

6. The method of claim 1, which further comprises incorporating an additional agent selected from the group consisting of excipients, growth factors, vitamins, minerals, ions, gases, crosslinking agents, active agents, carriers and combinations thereof.

7. The method of claim 6, wherein the gases are selected from the group consisting of oxygen, nitrogen and mixtures thereof.

8. The method of claim 1, wherein said three-dimensional polymer microenvironment is a crosslinked hydrogel system.

9. The method of claim 1, wherein said three-dimensional polymer microenvironment is crosslinked using genipin, transglutaminase, ribosylation and combinations thereof.

10. The method according to claim 1, wherein said method further includes adding a polymeric filler material prior to step (iv) to aid in harvesting of the three-dimensional polymer microenvironments, wherein said polymeric filler material is removed following collection of the three-dimensional polymer microenvironments.

11. The method according to claim 10, wherein said polymeric filler material comprises gelatin.

12. The method of claim 1, wherein said stem cells are obtained from bone marrow or cord.

13. The method of claim 1, wherein said stem cells are adult stem cells.

14. The method of claim 1, wherein said stem cells are human mesenchymal stem cells (hMSCs).

15. The method of claim 1, wherein said stem cells are embryonic stem cells.

16. The method according to any one of claims 1 or 2, wherein said polymer microenvironments are beads having a size range of 20-1000 microns in diameter.

17. The method according to any one of claims 1 or 2, wherein said polymer microenvironments are beads having a size range of 20-200 microns in diameter.

18. A method of producing a population of differentiated viable stem cells, wherein said method comprises directed differentiation of stem cells by the following steps:

(i) mixing a polymer solution derived from living organisms with stem cells in a buffer to incorporate and disperse the stem cells therein to form a cell-liquid suspension,

(ii) emulsifying said cell-liquid suspension in a hydrophobic fluid phase to form an emulsified liquid,

(iii) initiating polymerization of said emulsified liquid to form three-dimensional polymer microenvironments,

(iv) collecting the three-dimensional polymer microenvironments via centrifugation, and

(v) culturing said three-dimensional polymer microenvironments to promote the directed differentiation of the embedded stem cells.

19. The method according to claim 18, wherein said hydrophobic fluid phase is selected from the group consisting of silicone oil, mineral oil, vegetable oil, room temperature ionic liquids and combinations thereof.

20. The method according to claim 18, wherein said polymer is selected from the group consisting of collagen, elastin, fibrinogen, fibrin, fibronectin, gelatin, laminin, vitronectin, hyaluronan, heparan sulfate, agar, agarose, alginate, chitosan and combinations thereof.

21. The method according to claim 18, wherein said polymer is selected from the group consisting of collagen-gelatin, collagen-agarose, collagen-chitosan, collagen-chitosan-agarose, collagen-chitosan-gelatin, collagen-vitronectin-agarose, collagen-vitronectin-gelatin, collagen-vitronectin-chitosan, collagen-fibronectin-agarose, collagen-fibronectin-gelatin collagen-fibronectin-chitosan, collagen-laminin-agarose, collagen-laminin-gelatin, collagen-laminin-chitosan.

22. The method of claim 18, wherein said three-dimensional polymer microenvironment is crosslinked using genipin, transglutaminase, ribosylation and combinations thereof.

23. The method according to claim 18, wherein said three-dimensional polymer microenvironment is a hydrogel bead.

24. The method of claim 18, wherein said stem cells are obtained from bone marrow or cord/placental blood.

25. The method of claim 18, wherein said stem cells are adult stem cells.

26. The method of claim 18, wherein said stem cells are human mesenchymal stem cells (hMSCs).

27. The method according to claim 18, wherein said polymer microenvironments are beads having a size range of 20-1000 microns in diameter.

28. The method according to claim 18 wherein said polymer microenvironments are beads having a size range of 20-200 microns in diameter.

29. The method of claim 18, which further comprises incorporating an additional agent selected from the group consisting of excipients, growth factors, vitamins, minerals, ions, gases, cross-linking agents, active agents, carriers and combinations thereof.

30. The method of claim 29, wherein the gases are selected from the group consisting of oxygen, nitrogen and mixtures thereof.

31. A method of encapsulating and delivering stem cells within hydrogel polymer microenvironments, wherein said method comprises the following sequential steps:

(i) mixing a polymer derived from living organisms with stem cells in a buffer to incorporate and disperse the stem cells therein to form a cell-liquid suspension,

(ii) emulsifying said cell-liquid suspension in a hydrophobic fluid phase to form an emulsified liquid,

(iii) initiating polymerization of said emulsified liquid to form polymer microenvironments,

(iv) collecting the polymer microenvironments from the hydrophobic phase,

(v) forming a concentrated paste of said polymer microenvironments, and

(vi) loading the paste into a syringe and extruding it for cosmetic or therapeutic application to a subject in need thereof.

32. The method according to claim 31, wherein said hydrophobic fluid phase is selected from the group consisting of silicone oil, mineral oil, vegetable oil, room temperature ionic liquids and combinations thereof.

33. The method according to claim 31, wherein said polymer is selected from the group consisting of collagen, elastin, fibrinogen, fibrin, fibronectin, gelatin, laminin, vitronectin, hyaluronan, heparan sulfate, agar, agarose, alginate, chitosan and combinations thereof.

34. The method according to claim 31, wherein said polymer is selected from the group consisting of collagen-gelatin, collagen-agarose, collagen-chitosan, collagen-chitosan-agarose, collagen-chitosan-gelatin, collagen-vitronectin-agarose, collagen-vitronectin-gelatin, collagen-vitronectin-chitosan, collagen-fibronectin-agarose, collagen-fibronectin-gelatin collagen-fibronectin-chitosan, collagen-laminin-agarose, collagen-laminin-gelatin, collagen-laminin-chitosan.

35. The method of claim 31, which further comprises incorporating an additional agent selected from the group consisting of excipients, growth factors, vitamins, minerals, ions, gases, cross-linking agents, active agents, carriers and combinations thereof.

36. The method of claim 35, wherein the gases are selected from the group consisting of oxygen, nitrogen and mixtures thereof.

37. The method of claim 31, wherein said stem cells are obtained from bone marrow or cord blood.

38. The method according to claim 31, wherein said method produces beads having a size range of 20-1000 microns in diameter.

39. The method according to claim 31, wherein said method produces beads having a size range of 20-200 microns in diameter.

40. The method according to claim 31, wherein said therapeutic application is tissue repair or regeneration.

41. The method according to claim 40, wherein said tissue repair or regeneration is selected from bone repair, nerve repair, cardiac muscle repair, skin repair and cartilage repair.

42. The method of claim 31, wherein the application of said paste is by injection or implantation directly to the application site.

43. The method of claim 31, wherein the application of said paste is directly to the site of bone injury to promote differentiation towards the osteoblastic phenotype.

44. The method of claim 31, wherein said therapeutic application causes directed differentiation of stem cells into cells selected from the group consisting of osteoblasts, chondroblasts, adipocytes, fibroblasts, endothelial cells, neurons, smooth muscle cells, skeletal myoblasts and cardiac myocytes.

45. The method of claim 44, wherein differentiation towards the osteoblastic phenotype results in therapies involving avascular necrosis, spinal fusion or implant fixation.